Provision of Samples. Company shall, within ​ of a request by Takeda, provide samples of any Bulk Drug Product alleged to be defective and copies of written reports or investigations performed to date by or on behalf of Company on such Bulk Drug Product.

Samples. Samples collected in the course of activities conducted under this Agreement shall be jointly owned by the Parties (to the extent not owned by the patient and/or the clinical trial site). Any such Samples shall be collected in accordance with the applicable Protocol and ICFs. Neither Party shall be permitted to use such Samples for any purpose without the prior

Samples. Urovant shall supply a reasonable quantity of samples of the Product to Sunovion to be used in connection with the Co-Promotion Activities. [* * *].

If available, Customer will provide all samples/materials necessary to perform this project. The samples/materials should arrive at Catalent with all proper documentation. If samples/materials are not available, upon request from Customer, Catalent will purchase all samples/materials necessary to perform the project. Where standard materials, such as excipients or columns are required, or needed to maintain the Project timeline, Catalent will purchase such materials. Catalent will invoice Customer monthly at cost plus reasonable and customary acquisition and handling costs for any material purchased as described above. Non-standard or special instrumentation or equipment required solely for this project will be invoiced to Customer following Customer’s approval.

Samples. Upon [[OUTSET:Organization]]’s request, Supplier shall provide [[OUTSET:Organization]] with a reasonable quantity of samples of Products from an [[OUTSET:Organization]] specified batch for inspection, testing and analysis. Supplier shall ship such sample Products as requested by [[OUTSET:Organization]], and [[OUTSET:Organization]] shall be responsible for the product cost and shipping expenses.

Samples. Upon Apellis’s request, [[Bachem CH:Organization]] will provide to Apellis, ​, samples of Drug Substance from an Apellis-specified Batch in quantities and sizes reasonably requested by Apellis, as set forth in [Schedule 2.11], for inspection, testing and analysis. [[Bachem CH:Organization]] will ship such samples, at Apellis’ cost, as requested by Apellis to a Apellis designated address.

Samples. Samples collected in the course of activities conducted under a Collaboration Study shall be jointly owned by the Parties (to the extent not owned by the patient and/or the clinical trial site). Any such Samples shall be collected in accordance with the applicable Protocol and ICFs. Neither Party shall be permitted to use such Samples for any purpose without the prior written consent of the other Party, which consent shall not be unreasonably withheld if such use is directed to the Monotherapy or Combined Therapy and with the terms of such use to be set forth in a written agreement between the Parties setting forth the Samples to be used, and any appropriate terms/restrictions on such use. Any data and intellectual property arising out of such Sample use shall be owned by the Lead Party conducting such study using the same; provided that to the extent that any such data or intellectual property relates solely to the Combined Therapy (or biomarkers solely for use with the Combined Therapy), such data or intellectual property shall be considered Collaboration Study Data or Joint Collaboration Inventions/Joint Collaboration Patent Rights, as the case may be. Samples for PK and ADA serum analysis will be stored for future use in the Lead Party’s sample repository, at its own expense;

Samples. Neither Party shall distribute any samples of Products without the prior written consent of the other Party.

Retained Samples. FIS shall retain samples from each batch of API for a period of one (1) year after the shipment of such batch to Purchaser or such longer period required by Laws or cGMPS and FIS internal procedure for record keeping, testing and regulatory purposes. FIS shall provide thirty (30) days notice to Purchaser prior to desctruction of any samples. Purchaser shall also have the right to retain, at its own cost, samples from each batch of API.

Samples. [[CoreRx:Organization]] shall retain samples of each batch of Product and in‑process materials for such batch for a period of ​ years after Client’s acceptance of such batch. The sample size shall be ​ the size necessary to conduct quality control testing. Upon Client’s written request, [[CoreRx:Organization]] shall provide Client with up to one-half the original amount of the retained samples.